FDA Grants Orphan Drug Tag to AGIO’s Tebapivat for Rare Cancer
ZacksThe FDA bestows an orphan drug designation to Agios’ PK activator, tebapivat, for treating myelodysplastic syndromes.
The FDA bestows an orphan drug designation to Agios’ PK activator, tebapivat, for treating myelodysplastic syndromes.